Organization

Abbott Laboratories

0 members

Corporate ratings

High Risk

Abbott Laboratories is rated high risk because it scored poorly across all measured categories, including cancellations, discriminatory philanthropy, employment protection, advocacy bias, funding, and political actions. The company is seen as prioritizing politically driven and identity-based initiatives over merit and core business objectives, which the report argues undermines free speech, free enterprise, and shareholder interests.

CancellationsHigh Risk
Discriminatory PhilanthropyHigh Risk
Employment ProtectionHigh Risk
Advocacy BiasHigh Risk
FundingHigh Risk
Political ActionsHigh Risk

In the news

coverage spread: L24/C35/R41

Photo: ajay_suresh / Wikimedia Commons (CC BY 2.0)

Business

Abbott Reaches $670M Settlement Over Preterm Formula Litigation

Abbott has reached a settlement with three law firms to resolve roughly 2,000 NEC-related infant claims tied to preterm formulas for about $670 million, a move that reduces litigation risk while Abbott and health authorities maintain formulas are safe. The company disclosed the settlement in an 8-K and noted ongoing lawsuits and bellwether cases across several jurisdictions as the broader fight over NEC risk in preterm formulas continues.

11 sources

Abbott Laboratories

Corporate ratings

In the news

Abbott Reaches $670M Settlement Over Preterm Formula Litigation

Articleresearching the web…

Abbott Laboratories

Corporate ratings

In the news

Abbott Reaches $670M Settlement Over Preterm Formula Litigation

Articleresearching the web…

Momentum